Andrew D. Lipman Sells 15,400 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman sold 15,400 shares of Nu Skin Enterprises stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $17.68, for a total value of $272,272.00. Following the transaction, the director now owns 37,225 shares of the company’s stock, valued at $658,138. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Nu Skin Enterprises Trading Down 0.7 %

NUS opened at $17.22 on Wednesday. The company has a quick ratio of 0.94, a current ratio of 1.62 and a debt-to-equity ratio of 0.44. The stock has a market cap of $860.31 million, a PE ratio of 14.59 and a beta of 1.19. The company has a fifty day moving average of $20.93 and a 200-day moving average of $28.11. Nu Skin Enterprises, Inc. has a twelve month low of $16.20 and a twelve month high of $45.55.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $0.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.08). The business had revenue of $498.80 million for the quarter, compared to the consensus estimate of $520.09 million. Nu Skin Enterprises had a return on equity of 13.44% and a net margin of 2.92%. Nu Skin Enterprises’s quarterly revenue was down 7.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.47 earnings per share. On average, sell-side analysts predict that Nu Skin Enterprises, Inc. will post 1.75 EPS for the current year.

Nu Skin Enterprises Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Friday, November 24th will be issued a $0.39 dividend. The ex-dividend date is Wednesday, November 22nd. This represents a $1.56 annualized dividend and a yield of 9.06%. Nu Skin Enterprises’s payout ratio is currently 132.20%.

Institutional Trading of Nu Skin Enterprises

Hedge funds have recently bought and sold shares of the business. AlphaCrest Capital Management LLC purchased a new position in Nu Skin Enterprises during the 1st quarter worth $336,000. MetLife Investment Management LLC grew its position in shares of Nu Skin Enterprises by 39.1% in the first quarter. MetLife Investment Management LLC now owns 58,476 shares of the company’s stock valued at $2,800,000 after purchasing an additional 16,431 shares in the last quarter. Panagora Asset Management Inc. bought a new stake in Nu Skin Enterprises during the 1st quarter worth approximately $385,000. Rhumbline Advisers lifted its position in Nu Skin Enterprises by 0.6% during the first quarter. Rhumbline Advisers now owns 148,426 shares of the company’s stock valued at $7,107,000 after purchasing an additional 849 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in shares of Nu Skin Enterprises by 10.5% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 18,260 shares of the company’s stock valued at $874,000 after buying an additional 1,741 shares in the last quarter. Institutional investors and hedge funds own 73.62% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on NUS shares. Citigroup decreased their target price on Nu Skin Enterprises from $30.00 to $23.00 and set a “neutral” rating on the stock in a research report on Friday, September 29th. StockNews.com began coverage on Nu Skin Enterprises in a research note on Thursday, October 5th. They set a “hold” rating for the company. TheStreet cut shares of Nu Skin Enterprises from a “c” rating to a “d+” rating in a report on Wednesday, November 1st. Stifel Nicolaus cut their price objective on Nu Skin Enterprises from $35.00 to $27.00 and set a “hold” rating on the stock in a report on Monday, October 16th. Finally, DA Davidson cut their target price on shares of Nu Skin Enterprises from $38.00 to $29.00 and set a “neutral” rating on the stock in a research report on Thursday, August 3rd. Five research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Nu Skin Enterprises currently has an average rating of “Hold” and a consensus target price of $29.50.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products.